Compounds > cefotiam
Page last updated: 2024-08-23

cefotiam and imipenem, anhydrous

cefotiam has been researched along with imipenem, anhydrous in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's8 (80.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J1
Matsumoto, K; Nagatake, T1
Neu, HC1
Matsuo, K; Uete, T1
Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T1
Hori, K; Ishikawa, S; Mashita, K; Mizuno, A; Shinagawa, N; Yura, J1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Suzuki, K; Suzuki, Y; Yokota, N1
Asahi, Y; Goto, M; Inoue, M; Kaji, Y; Kimura, S; Matsuda, K; Nakagawa, S; Oka, S; Sanada, M; Shimada, K1
Adachi, Y; Inoue, M; Kawakami, M; Matsuda, K; Nakamura, K1
Akaike, N; Fujimoto, M; Munakata, M1

Reviews

1 review(s) available for cefotiam and imipenem, anhydrous

ArticleYear
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Annual review of pharmacology and toxicology, 1982, Volume: 22

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam

1982

Other Studies

9 other study(ies) available for cefotiam and imipenem, anhydrous

ArticleYear
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei

2009
[Drug therapy of intractable methicillin-resistant staphylococcal infections].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Dec-10, Volume: 79, Issue:12

    Topics: Cefotiam; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Methicillin Resistance; Minocycline; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

1990
Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    The Japanese journal of antibiotics, 1995, Volume: 48, Issue:3

    Topics: Cefamandole; Cefazolin; Cefoperazone; Cefotiam; Cephalothin; Drug Resistance, Microbial; Drug Synergism; Imipenem; Methicillin Resistance; Staphylococcus aureus

1995
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus

1994
[Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cilastatin; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection

1994
[Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. I. Synergistic actions of cefotiam with imipenem and vancomycin].
    The Japanese journal of antibiotics, 1993, Volume: 46, Issue:2

    Topics: Cefotiam; Drug Synergism; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin

1993
Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:4

    Topics: Animals; Cefotiam; Cilastatin; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Imipenem; Kinetics; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Staphylococcal Infections; Staphylococcus aureus

1993
Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:12

    Topics: Bacterial Proteins; Bacteriolysis; Base Sequence; Carrier Proteins; Cefotiam; Cephalosporins; Drug Synergism; Hexosyltransferases; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Polymerase Chain Reaction; Staphylococcus aureus; Thienamycins

1995
Dual mechanisms of GABAA response inhibition by beta-lactam antibiotics in the pyramidal neurones of the rat cerebral cortex.
    British journal of pharmacology, 1995, Volume: 116, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Aztreonam; Cefotiam; Chloride Channels; GABA-A Receptor Antagonists; Imipenem; In Vitro Techniques; Patch-Clamp Techniques; Penicillin G; Penicillins; Pyramidal Cells; Rats; Rats, Wistar

1995